These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551 [TBL] [Abstract][Full Text] [Related]
3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C; HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771 [TBL] [Abstract][Full Text] [Related]
4. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M; Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597 [TBL] [Abstract][Full Text] [Related]
5. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy. Sitia G; De Bona A; Bagaglio S; Galli L; Paties CT; Uberti-Foppa C; Guidotti LG; Lazzarin A; Morsica G Antivir Ther; 2006; 11(3):385-9. PubMed ID: 16759056 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection? Bäuerle J; Laguno M; Mauss S; Mallolas J; Murillas J; Miquel R; Schmutz G; Setzer B; Gatell JM; Walker UA HIV Med; 2005 Mar; 6(2):135-9. PubMed ID: 15807720 [TBL] [Abstract][Full Text] [Related]
7. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133 [TBL] [Abstract][Full Text] [Related]
9. HIV and hepatitis C coinfection. Matthews GV; Dore GJ J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597 [TBL] [Abstract][Full Text] [Related]
10. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients. Monto A; Kakar S; Dove LM; Bostrom A; Miller EL; Wright TL Am J Gastroenterol; 2006 Jul; 101(7):1509-15. PubMed ID: 16863554 [TBL] [Abstract][Full Text] [Related]
11. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. Thein H; Maruff P; Krahn M; Kaldor J; Koorey Dj; Brew B; Dore G HIV Med; 2007 Apr; 8(3):192-202. PubMed ID: 17461864 [TBL] [Abstract][Full Text] [Related]
12. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop. Carosi G; Puoti M; Antonucci G; De Luca A; Maserati R; Torti C; Bonfanti P; Bonora S; Bruno R; Gaeta GB; Antinori A; Monforte Ad; Orani A; Sagnelli E; Cargnel A; Cauda R; Mazzotta F; Pastore G; Suter F; Vullo V; ; AIDS Rev; 2005; 7(3):161-7. PubMed ID: 16302464 [TBL] [Abstract][Full Text] [Related]
14. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy. Pineda JA; Macías J J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202 [TBL] [Abstract][Full Text] [Related]
15. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. Gatti F; Nasta P; Loregian A; Puoti M; Matti A; Pagni S; de Requena DG; Prestini K; Parisi SG; Bonora S; Palù G; Carosi G J Antimicrob Chemother; 2009 Mar; 63(3):575-8. PubMed ID: 19151039 [TBL] [Abstract][Full Text] [Related]
17. [Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications]. Jabłonowska E Przegl Epidemiol; 2004; 58(4):621-8. PubMed ID: 15810503 [TBL] [Abstract][Full Text] [Related]
18. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. Weissbrich B; Langmann P; Schubert J; Jassoy C; Klinker H Eur J Med Res; 2003 Nov; 8(11):495-8. PubMed ID: 14644704 [TBL] [Abstract][Full Text] [Related]
19. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects. Marcellin F; Préau M; Dellamonica P; Ravaux I; Kurkdji P; Protopopescu C; Carrieri MP; Spire B J Pain Symptom Manage; 2007 Oct; 34(4):413-21. PubMed ID: 17616331 [TBL] [Abstract][Full Text] [Related]